Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Provision of Organ at Risk Contouring Guidance in UK Radiotherapy Clinical Trials.

Yang H, Mir R, Díez P, Tsang Y, Conibear J, Simões R, Cox S, Webster A, Nabi Z, Eaton D, Naismith O, Whilde N, Miles E.

Clin Oncol (R Coll Radiol). 2019 Oct 11. pii: S0936-6555(19)30433-9. doi: 10.1016/j.clon.2019.09.054. [Epub ahead of print]

PMID:
31607614
2.

Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor-Positive Metastatic Breast Cancer: The MANTA Phase 2 Randomized Clinical Trial.

Schmid P, Zaiss M, Harper-Wynne C, Ferreira M, Dubey S, Chan S, Makris A, Nemsadze G, Brunt AM, Kuemmel S, Ruiz I, Perelló A, Kendall A, Brown J, Kristeleit H, Conibear J, Saura C, Grenier J, Máhr K, Schenker M, Sohn J, Lee KS, Shepherd CJ, Oelmann E, Sarker SJ, Prendergast A, Marosics P, Moosa A, Lawrence C, Coetzee C, Mousa K, Cortés J.

JAMA Oncol. 2019 Aug 29. doi: 10.1001/jamaoncol.2019.2526. [Epub ahead of print]

PMID:
31465093
3.

Thoracic intervention and surgery to cure lung cancer: an overview of stereotactic ablative radiotherapy in early and oligometastatic lung cancer.

Chia B, Landau D, Hanna G, Conibear J.

J R Soc Med. 2019 Aug;112(8):334-340. doi: 10.1177/0141076818763334. Epub 2018 Apr 19. No abstract available.

PMID:
29672204
4.

Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer.

Conibear J, Chia B, Ngai Y, Bates AT, Counsell N, Patel R, Eaton D, Faivre-Finn C, Fenwick J, Forster M, Hanna GG, Harden S, Mayles P, Moinuddin S, Landau D.

BMJ Open. 2018 Apr 17;8(4):e020690. doi: 10.1136/bmjopen-2017-020690. Erratum in: BMJ Open. 2019 May 9;9(5):e020690corr1.

5.

Practical multimodal care for cancer cachexia.

Maddocks M, Hopkinson J, Conibear J, Reeves A, Shaw C, Fearon KC.

Curr Opin Support Palliat Care. 2016 Dec;10(4):298-305. Review.

6.

Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark case.

Gwynne S, Spezi E, Sebag-Montefiore D, Mukherjee S, Miles E, Conibear J, Staffurth J; NCRI RTTQA OUTLINING AND IMAGING SUBGROUP.

Br J Radiol. 2013 Apr;86(1024):20120398. doi: 10.1259/bjr.20120398. Epub 2013 Feb 7. Review.

7.

High-precision MRI-guided adaptive brachytherapy for cervical carcinoma.

Conibear J, Lowe G, Hoskin PJ.

Int J Hyperthermia. 2012;28(6):501-8. doi: 10.3109/02656736.2012.683847. Epub 2012 Jul 26. Review.

PMID:
22834543
8.

Dose-modified XELIRI chemotherapy for metastatic colorectal cancer--a retrospective study of 78 patients.

Tarver K, Conibear J, Raouf S.

Clin Oncol (R Coll Radiol). 2012 Aug;24(6):453-4. doi: 10.1016/j.clon.2012.03.003. Epub 2012 Apr 1. No abstract available.

PMID:
22472457
9.

Bevacizumab treatment for vestibular schwannomas in neurofibromatosis type two: report of two cases, including responses after prior gamma knife and vascular endothelial growth factor inhibition therapy.

Eminowicz GK, Raman R, Conibear J, Plowman PN.

J Laryngol Otol. 2012 Jan;126(1):79-82. doi: 10.1017/S0022215111002805. Epub 2011 Oct 18.

PMID:
22004800

Supplemental Content

Loading ...
Support Center